Idorsia aims to be Europe’s leading biopharmaceutical company, with a strong scientific core. We provide regular updates on the progress being made towards this goal. This section of the website provides journalists with additional material to support the generation of articles.

Events

Event When
J.P. Morgan Healthcare Conference

Press release
Presentation (PDF; Webcast)

Goldman Sachs Biotech Symposium September 7, 2021
Citi's Annual BioPharma Conference September 8-10, 2021
Morgan Stanley Global Healthcare Conference September 9-15, 2021
BofA Global Healthcare Conference September 15-17, 2021
Baader Investment Conference September 20-24, 2021
Nine-months 2021 Financial Results reporting* October 26, 2021
Full-Year 2021 Financial Results reporting* February 8, 2022
First-Quarter 2022 Financial Results reporting*
April 26, 2022

*We will be in a silent period for 10 days ahead of the financial reporting.

Stay informed

Idorsia offers an electronic ‘Stay Informed’ service where subscribers can automatically receive updates via e-mail or SMS alert.

Stay informed

Social Media

Idorsia is active on social media – follow our channels to get a more personal view on the company.

Social Media

Media center

Idorsia provides images, fact sheets and B-roll to download or support you with your article.

Media center

Contact

Contact

Andrew C. Weiss

Senior Vice President, Head of Investor Relations and Corporate Communications

Media Relations

Resources in German

Als schweizerisches Unternehmen stellen wir interessierten Personen auf dieser Seite wesentliche Informationen über unser Unternehmen in deutscher Sprache zur Verfügung.